RIGHT REMEDIES Maximum Strength Urinary Pain Relief

RIGHT REMEDIES Maximum Strength Urinary Pain Relief is an FDA drug label for the active ingredient PHENAZOPYRIDINE HYDROCHLORIDE manufactured by Strive Pharmaceuticals Inc. administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231122.

Generic: PHENAZOPYRIDINE HYDROCHLORIDE

Manufacturer: Strive Pharmaceuticals Inc.

Product Type: HUMAN OTC DRUG

Route: ORAL

Dosage Form:

NDC: 70692-163

Application:

Effective: 20231122

Active Ingredients: Active ingredient (in each tablet) Phenazopyridine Hydrochloride 99.5 mg

Indications & Usage

Use Relief from urinary pain, burning, urgency and frequency associated with urinary tract infections. Treatment should not exceed 2 days; see Directions

Dosage & Administration

Directions • Adults and children 12 years and over: Take 2 tablets 3 times daily with or after meals as needed for up to two days. Take with a full glass of water. Do not use for more than 2 days (12 tablets) without consulting a doctor • Children under 12 years: Do not use without consulting a doctor

Contraindications

Not available.

Warnings

Warnings Do not exceed recommended dosage Do not use if you have Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency unless approved by your physician. Ask a doctor before use if you have • kidney disease • allergies to foods, preservatives or dyes • had a hypersensitive reaction to Phenazopyridine Hydrochloride When using this product • stomach upset may occur, taking this product with or after meals may reduce stomach upset • your urine will become reddish orange in color. This is not harmful, but care should be taken to avoid staining clothing or other items. Stop use and ask a doctor if • your symptoms last for more than 2 days • you suspect you are having an adverse reaction to the medication. Long-term administration of Phenazopyridine HCl has induced neoplasia in rats (large intestine) and mice (liver). Although no association between Phenazopyridine HCl and human neoplasia has been reported, adequate epidemiological studies along these lines have not been conducted. If pregnant or breastfeeding , ask a health professional before use. A pregnancy test and consultation with a health professional if pregnancy is confirmed is recommended prior to use. Keep out of reach of children. In case of an overdose, get medical help or contact a Poison Control Center right away.

Adverse Reactions

Not available.

More from same ingredient

Phenazopyridine Hydrochloride

Westminster Pharmaceuticals, LLC

Phenazopyridine Hydrochloride

Winder Laboratories, LLC

URO-PAIN

Rising Pharma Holdings, Inc.